预防性静脉钙在预防子痫前期产妇剖宫产腰麻后低血压中的作用:安慰剂对照随机临床试验
本研究为前瞻性、随机、安慰剂对照、双盲、双臂平行试验,纳入100例子痫前期接受硫酸镁补充并剖宫产的产妇,随机在腰麻前接受静脉葡萄糖酸钙500 mg或生理盐水。钙组腰麻后低血压发生率显著低于安慰剂组(32% vs 60%;RR 1.87 [95%CI 1.18-2.97];P=.007),去氧肾上腺素和甲氧明需求量及产后出血量也显著降低,但新生儿结局和母体血清钙无显著差异。
要点
- 钙组腰麻后低血压发生率为32%,安慰剂组为60%,差异有统计学意义(P=.007)。
- 钙组去氧肾上腺素和甲氧明需求量均显著低于安慰剂组。
- 钙组产后出血量显著低于安慰剂组,但新生儿结局无显著差异。
核心结论
- 预防性静脉补钙可显著降低接受硫酸镁补充的子痫前期产妇剖宫产腰麻后低血压的发生率。
- 预防性补钙减少产后出血的效果令人鼓舞,但需要大型试验验证本研究结果。
研究设计与样本
- 前瞻性、随机、安慰剂对照、双盲、双臂平行试验,在子痫前期接受硫酸镁补充并剖宫产的产妇中开展。
- 共100例产妇完成研究,钙组和安慰剂组各50例。
- 研究药物为葡萄糖酸钙500 mg或生理盐水,于腰麻前15分钟内静脉输注,输注结束即开始腰麻。
主要发现
- 腰麻后低血压发生率钙组32% vs 安慰剂组60%(RR 1.87 [95%CI 1.18-2.97];P=.007),钙组显著低于安慰剂组。
- 去氧肾上腺素平均需求量钙组5.60±14.59 mcg vs 安慰剂组14.80±22.42 mcg(P=.01),钙组显著低于安慰剂组。
- 甲氧明平均需求量钙组3.30±5.11 mg vs 安慰剂组5.82±4.97 mg(P=.008),钙组显著低于安慰剂组。
- 产后平均出血量钙组406.90±94.34 ml vs 安慰剂组472.20±122.49 ml(P=.004),钙组显著低于安慰剂组。
- 新生儿重症监护室入住率、Apgar评分、脐动脉pH值及母体血清钙两组相当。
局限性
- 作者指出需要大型试验来验证本研究的结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preeclamptic women, in addition to traditional antihypertensive medications, often receive magnesium supplementation and are at increased risk of postspinal hypotension Postspinal hypotension increases the risk of fetomaternal morbidity. Calcium is a physiological antagonist of magnesium in vascular smooth muscle. Therefore, the study hypothesized that calcium is better suited for preserving systemic vascular resistance and preventing postspinal hypotension during cesarean delivery. OBJECTIVES: The study aimed to evaluate the effect of prophylactic calcium administration on postspinal hypotension in preeclamptic women receiving magnesium supplementation. METHODS: This prospective, randomized, placebo-controlled, double-blinded, two-arm parallel trial was conducted in preeclamptic women receiving magnesium sulfate supplementation undergoing cesarean delivery. The women were randomized to receive intravenous calcium or a placebo (normal saline) before spinal anesthesia. The study drug (calcium gluconate 500 mg or normal saline) was administered over 15 minutes and ended immediately before spinal anesthesia. The primary outcome measure was the incidence of postspinal hypotension, and secondary outcome measures were postpartum blood loss and maternal and neonatal outcomes. RESULTS: A total of 100 women (50 each calcium and placebo arm) completed the study. The baseline demographic variables, mean blood pressure and heart rate were comparable. The incidence of postspinal hypotension was significantly lower in the calcium arm compared to the placebo arm (32% vs 60%; Relative risk [95% CI]; 1.87 [1.18-2.97]; P=.007). The mean phenylephrine requirement (5.60±14.59 vs 14.80±22.42 mcg; P=.01) and mephentermine requirement (3.30±5.11 mg vs 5.82±4.97 mg; P=.008) was significantly lower in the calcium group. Furthermore, the calcium group's mean postpartum blood loss was significantly lower (406.90±94.34 vs 472.20±122.49 ml, P=.004). However, the Neonatal Intensive Care Unit admission rate, Apgar score, umbilical artery PH, and maternal serum calcium were comparable. CONCLUSION: Prophylactic calcium infusion significantly reduces the incidence of postspinal hypotension during cesarean delivery in preeclamptic women receiving magnesium supplementation. Furthermore, the effect of prophylactic calcium in decreasing postpartum blood loss is encouraging. However, large trials are required to validate the findings of this study.
引用
- Yadav NK, Lata S, Jha N, et al. Role of prophylactic intravenous calcium in prevention of postspinal hypotension among women with preeclampsia undergoing cesarean delivery: a placebo controlled randomized clinical trial. Am J Obstet Gynecol MFM. 2024. PMID: 39536834. doi:10.1016/j.ajogmf.2024.101541
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。